Vitti Long Haul

Vitti Long Haul is dedicated to transforming care for people affected by long COVID symptoms and pulmonary fibrosis through advanced regenerative medicine. Our therapies, VL-PX10 and VL-P22, are created using mesenchymal stem cells, exosomes, and biomaterials, and are currently being evaluated in Phase 2 human clinical trials. We also offer a physician-supervised Expanded Access Program for patients who may not qualify for ongoing studies. Guided by FDA standards and extensive scientific research, our mission is to provide innovative and safe treatment options that support recovery and healing. Vitti Long Haul continues to work closely with patients and physicians to improve long-term health outcomes and quality of life.